Bill > HB1212

This bill addresses two key areas: drug screening and fatherhood engagement in maternal health. For drug screening, the bill modifies existing law to clarify that urine drug screening requirements do not apply when a healthcare provider determines a positive fentanyl test is due to a legally prescribed treatment. The more substantial portion of the bill focuses on fatherhood engagement, establishing a framework to promote fathers' involvement in maternal and infant healthcare. The bill requires the Department of Health to develop a public awareness campaign highlighting the importance of fathers during pregnancy and early childhood, including messaging about fathers' roles in recognizing potential health complications, supporting maternal mental health, attending prenatal appointments, and promoting infant development. The campaign will provide resources countering narratives that minimize fathers' importance and offer information about specific health benefits of father involvement, such as increased likelihood of early prenatal care and reduced risks of postpartum mood disorders. Additionally, the bill directs the department to create guidance for healthcare providers on engaging fathers, including screening for paternal depression and providing education about pregnancy, childbirth, and child care. The legislation also mandates that the Joint State Government Commission conduct a study and report on the implementation of these provisions within four years, ensuring ongoing evaluation of the program's effectiveness.

Budget and Finance, Health and Social Services

https://www.legis.state.pa.us/cfdocs/billinfo/bill_history.cfm?syear=2025&sind=0&body=H&type=B&bn=1212